Profile of Pulmonary Tuberculosis Patients with Type 2 Diabetes Mellitus in Pulmonary Department Dr. Soetomo General Hospital Surabaya
Downloads
Background: Pulmonary tuberculosis (TB) is the most important infectious disease, caused by Mycobacterium tuberculosis (MTB). Indonesia is the third country with the most prevalent TB cases in the world. Not all people who were exposed to MTB will become active TB, because the immune response is the main determinant. Immunocompromised person, such as patients who have type 2 diabetes mellitus (DM) as a comorbid are more prone to develop active TB infection. This study aimed to analyze the profile of pulmonary TB patients with type 2 DM in Pulmonary Department Dr. Soetomo General Hospital Surabaya.
Methods: This was an observational descriptive study with a cross-sectional design. The research data were obtained from the medical records of TB patients with type 2 DM in Pulmonary Department Dr. Soetomo General Hospital Surabaya in January - December 2017.
Results: Out of a total of 414 hospitalized patients, 74 patients with pulmonary TB were found with type 2 DM. Only 53 patients fulfilled the inclusion criteria. Gene Xpert results were sensitive (66.7%), previous TB treatment history (54.7%), unregulated type 2 DM (88.4%), RBG with the average of 311.83 mg/dl, PPBS with the average of 263.31 mg/dl, FBG with the average of 238 mg/dl, and HbA1C > 10% (68%).
Conclusion: The majority of the patients of pulmonary TB with type 2 DM have average high blood glucose and unregulated DM.
Indonesia KKR. Profil Kesehatan Indonesia 2016. Jakarta: Kementerian Kesehatan Republik Indonesia, 2017.
Federation ID. What is Diabetes. Brussels: International Diabetes Federation, 2018.
Restrepo BI and Schlesinger LS. Host-Pathogen Interactions in Tuberculosis Patients with Type 2 Diabetes Mellitus. Tuberculosis (Edinburgh, Scotland). 2013; 93 Suppl: S10-4.
Federation ID. IDF Diabetes Atlas. 8th Ed. Brussels: International Diabetes Federation, 2017.
Use of Glycated Haemoglobin (HbA1C) in the Diagnosis of Diabetes Mellitus. Diabetes Research and Clinical Practice. 2011; 93: 299-309.
Bacakoglu F, Basoglu OK, Cok G, Sayiner A and Ates M. Pulmonary Tuberculosis in Patients with Diabetes Mellitus. Respiration; International Review of Thoracic Diseases. 2001; 68: 595-600.
Guptan A and Shah A. Tuberculosis and Diabetes: An Appraisal. Ind J Tub. 2000; 47: 3-8.
Indonesia PE. Konsensus Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia 2015. Jakarta: PB Perkeni, 2015.
Zahrotun N, Fatur Nur K and Dwi N. Prevalensi Terjadinya Tuberkulosis pada Pasien Diabetes Mellitus di RSUP Dr. Kariadi Semarang. Jurnal Kedokteran Diponegoro. 2015; 4: 1714-25.
Novita E, Ismah Z and Pariyana P. Angka Kejadian Diabetes Melitus pada Pasien Tuberkulosis. 2018. 2018; 5: 6.
Sharma D, Goel NK, Sharma MK, Walia DK, Thakare MM and Khaneja R. Prevalence of Diabetes Mellitus and Its Predictors among Tuberculosis Patients Currently on Treatment. Indian J Community Med. 2018; 43: 302-6.
Fitri Fauzia D. Insidensi Tuberkulosis Paru pada Pasien Diabetes Melitus Tipe 2 di Ruang Rawat Inap Penyakit Dalam RSUP Dr. M. Djamil Padang. Fakultas Kedokteran, Universitas Andalas, 2016.
Putra BE. Pengaruh Usia terhadap Prevalensi Tuberkulosis Paru pada Pasien Diabetes Melitus Tipe 2 di Rumah Sakit Dr. Cipto Mangunkusumo pada Tahun 2010. Jakarta: Universitas Indonesia, 2012.
Organization WH. Fact Sheets on Tuberculosis. Geneva: World Health Organization, 2018.
Chang JT, Dou HY, Yen CL, et al. Effect of Type 2 Diabetes Mellitus on the Clinical Severity and Treatment Outcome in Patients with Pulmonary Tuberculosis: A Potential Role in the Emergence of Multidrug-Resistance. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 2011; 110: 372-81.
Baker MA, Harries AD, Jeon CY, et al. The Impact of Diabetes on Tuberculosis Treatment Outcomes: A Systematic Review. BMC Medicine. 2011; 9: 81.
Mehta S, Yu EA, Ahamed SF, Bonam W and Kenneth J. Rifampin Resistance and Diabetes Mellitus in a Cross-Sectional Study of Adult Patients in Rural South India. BMC Infectious Diseases. 2015; 15: 451.
Baghaei P, Marjani M, Javanmard P, Tabarsi P and Masjedi MR. Diabetes Mellitus and Tuberculosis Facts and Controversies. Journal of Diabetes and Metabolic Disorders. 2013; 12: 58.
Mihardja L, Lolong DB and Ghani L. Prevalensi Diabetes Melitus pada Tuberkulosis dan Masalah Terapi. Jurnal Ekologi Kesehatan. 2015: 350-8.
Federation ID. Recommendations for Managing Type 2 Diabetes in Primary Care. In: Practice IC, (Ed.). Brussels: International Diabetes Federation, 2017.
Association AD. Factors Affecting Blood Glucose. Virginia: American Diabetes Association, 2019.
Amare H, Gelaw A, Anagaw B and Gelaw B. Smear Positive Pulmonary Tuberculosis among Diabetic Patients at the Dessie Referral Hospital, Northeast Ethiopia. Infect Dis Poverty. 2013; 2: 6-.
Agarwal AK, Gupta G, Marskole P and Agarwal A. A Study of the Patients Suffering from Tuberculosis and Tuberculosis-Diabetes Comorbidity in Revised National Tuberculosis Control Program Centers of Northern Madhya Pradesh, India. Indian J Endocrinol Metab. 2017; 21: 570-6.
Fahmi MA. Prevalensi Diabetes Mellitus Tipe 2 pada Pasien Tuberkulosis di Kabupaten Temanggung Jawa Tengah. Institut Ilmu Kesehatan Bhakti Wiyata Kediri, 2017.
Bailey SL and Grant P. 'The Tubercular Diabetic': The Impact of Diabetes Mellitus on Tuberculosis and Its Threat to Global Tuberculosis Control. Clin Med (Lond). 2011; 11: 344-7.
Indonesia KKR. Pedoman Nasional Pengendalian Tuberkulosis. Jakarta: Kementerian Kesehatan Republik Indonesia, 2014.
Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF Diabetes Atlas: Global Estimates for the Prevalence of Diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017; 128: 40-50.
Pande T, Huddart S, Xavier W, et al. Prevalence of Diabetes Mellitus amongst Hospitalized Tuberculosis Patients at an Indian Tertiary Care Center: A Descriptive Analysis. Plos One. 2018; 13: E0200838.
Manjareeka M, Palo SK, Swain S, Pati S and Pati S. Diabetes Mellitus among Newly Diagnosed Tuberculosis Patients in Tribal Odisha: An Exploratory Study. Journal of Clinical and Diagnostic Research : Jcdr. 2016; 10: Lc06-Lc8.
Van Crevel R, Ottenhoff TH and van Der Meer JW. Innate Immunity to Mycobacterium Tuberculosis. Clinical Microbiology Reviews. 2002; 15: 294-309.
Mahishale V, Avuthu S, Patil B, Lolly M, Eti A and Khan S. Effect of Poor Glycemic Control in Newly Diagnosed Patients with Smear-Positive Pulmonary Tuberculosis and Type-2 Diabetes Mellitus. Iranian Journal of Medical Sciences. 2017; 42: 144+.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.
JR (